Results 11 to 20 of about 89 (54)

A systematic review of fluralaner as a treatment for ectoparasitic infections in mammalian species [PDF]

open access: yesPeerJ
Fluralaner (Bravecto™) is a novel isoxazoline ectoparasiticide used for controlling ectoparasites of domestic mammals and is increasingly being used on wildlife. The aim of this systematic review was to evaluate the efficacy, pharmacokinetics, and safety
Yuanting Jiang, Julie M. Old
doaj   +3 more sources

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs [PDF]

open access: yesParasites & Vectors, 2014
Background Fluralaner, a new molecular entity of the isoxazoline class, has potent insecticidal and acaricidal activity and can be safely administered orally to dogs.
Nadja Rohdich   +2 more
doaj   +2 more sources

Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin) [PDF]

open access: yesParasites & Vectors, 2014
Background Bravecto™ (fluralaner; MSD Animal Health) is a novel systemic ectoparasiticide for dogs providing long-acting flea- and tick-control after a single oral dose.
Feli M Walther   +4 more
doaj   +2 more sources

Fluralaner, a novel isoxazoline, prevents flea (Ctenocephalides felis) reproduction in vitro and in a simulated home environment [PDF]

open access: yesParasites & Vectors, 2014
Background Fluralaner, a novel isoxazoline, has both acaricidal and insecticidal activity through potent blockage of GABA- and L-glutamate-gated chloride channels.
Heike Williams   +4 more
doaj   +2 more sources

Color dilution alopecia in a Yorkshire

open access: yesBrazilian Journal of Veterinary Pathology, 2022
A 1-year-old female Yorkshire terrier was presented to the clinic for a second opinion regarding its poor hair coat condition. According to the owner, the dog has been showing that appearance since the moment it was adopted, at 8 months of age. The owner
Tomás Rodrigues Magalhães   +1 more
doaj   +1 more source

Safety of fluralaner chewable tablets (BravectoTM), a novel systemic antiparasitic drug, in dogs after oral administration

open access: yesParasites & Vectors, 2014
Background Fluralaner is a novel systemic insecticide and acaricide that provides long acting efficacy in dogs after a single oral treatment. This study investigated the safety of oral administration of fluralaner in chewable tablets to dogs at the ...
Feli M Walther   +3 more
doaj   +1 more source

Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration

open access: yesParasites & Vectors, 2014
Background Fluralaner is a novel systemic ectoparasiticide for dogs providing long-acting flea- and tick-control after a single oral dose. This study investigated the safety of oral administration of fluralaner at 3 times the highest expected clinical ...
Feli M Walther   +4 more
doaj   +1 more source

A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations

open access: yesParasites & Vectors, 2014
Background The novel isoxazoline molecule fluralaner provides 12 weeks activity against fleas and 8 to 12 weeks against tick infestations according to label claims.
Cheyney Meadows   +2 more
doaj   +1 more source

Pharmacokinetics of fluralaner as a systemic drug to control infestations of the common bed bug, Cimex lectularius, in poultry facilities. [PDF]

open access: yesParasit Vectors, 2023
González-Morales MA   +9 more
europepmc   +1 more source

Treatment of dogs with Bravecto® (fluralaner) reduces mosquito survival and fecundity. [PDF]

open access: yesParasit Vectors, 2023
Evans CC   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy